Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Market Cap	11.91B +1.2%
Revenue (ttm)	1.25B +14.2%
Net Income	253.41M +144.8%
EPS	0.43 +144.1%
Shares Out	n/a
PE Ratio	46.99
Forward PE	39.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,167
Open	23.02
Previous Close	23.02
Day's Range	23.02 - 23.02
52-Week Range	16.35 - 25.69
Beta	0.85
RSI	52.43
Earnings Date	May 25, 2026

About FSPKF

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,412
• Stock Exchange: OTCMKTS
• Ticker Symbol: FSPKF

Financial Performance

In fiscal year 2025, FSPKF's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.

Financial numbers in NZD